RxDoctor Payments Data

Marilyn Conlon

Psychiatry · Traverse City, MINPI 1548373186

Payments from drug & device makers

$4,579in general payments, 2019–2025

Across 179 payments — averaging $25.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$967
  • Johnson & Johnson$578
  • Vanda Pharmaceuticals Inc.$488
  • Neurocrine Biosciences, Inc.$425
  • Lundbeck LLC$383
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$244
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$4,577100%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,579 in reported general payments places this provider in the 90th percentile of 1,166 psychiatry providers in Michigan.

See all psychiatry providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
FanaptIloperidone14$28,736
NuedextaDextromethorphan Hbr/Quinidine12$19,682
LamictalLamotrigine12$19,545
SuboxoneBuprenorphine Hcl/Naloxone Hcl12$6,879
Fluphenazine Hcl12$4,652
Gabapentin57$4,386
Lacosamide13$3,831
Carbamazepine ErCarbamazepine23$3,056
Thiothixene24$2,763
Vilazodone Hcl19$1,933
Memantine Hcl ErMemantine Hcl11$1,743
Quetiapine Fumarate70$1,652
Olanzapine62$1,449
Duloxetine Hcl36$1,372
Trazodone Hcl42$1,167

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Vanda Pharmaceuticals Inc.Fanapt$488$28,73614 claims
Avanir Pharmaceuticals, Inc.Nuedexta$80$19,68212 claims
Indivior Inc.Suboxone$212$6,87912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,166 psychiatry providers in Michigan.

Other psychiatry in Traverse City

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →